210174-73-5 Usage
Description
1,5-Dideoxy-1,5-imino-L-fucitol hydrochloride is a tan solid that serves as a powerful and specific inhibitor of several alpha-L-fucosidases. 1,5-Dideoxy-1,5-imino-L-fucitol hydrochloride is known for its ability to inhibit the activity of these enzymes, which play a crucial role in various biological processes.
Uses
Used in Pharmaceutical Industry:
1,5-Dideoxy-1,5-imino-L-fucitol hydrochloride is used as an inhibitor for alpha-L-fucosidases due to its powerful and specific inhibitory action. This application is particularly relevant in the development of therapeutic strategies for conditions where the inhibition of these enzymes can lead to positive health outcomes.
Used in Research and Development:
In the field of research and development, 1,5-Dideoxy-1,5-imino-L-fucitol hydrochloride is utilized as a tool to study the function and role of alpha-L-fucosidases in various biological processes. By inhibiting these enzymes, researchers can gain insights into their mechanisms of action and potential therapeutic targets for drug development.
Used in Drug Design and Synthesis:
The compound is also used in drug design and synthesis, where its inhibitory properties can be leveraged to create new drugs targeting alpha-L-fucosidases. This can be particularly useful in the development of treatments for diseases where these enzymes play a significant role in the pathology of the condition.
Check Digit Verification of cas no
The CAS Registry Mumber 210174-73-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,0,1,7 and 4 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 210174-73:
(8*2)+(7*1)+(6*0)+(5*1)+(4*7)+(3*4)+(2*7)+(1*3)=85
85 % 10 = 5
So 210174-73-5 is a valid CAS Registry Number.
210174-73-5Relevant articles and documents
Preparation of 1,6-di-deoxy-D-galacto and 1,6-di-deoxy-L-altro nojirimycin derivatives by aminocyclization of a 1,5-dicarbonyl derivative
Cuffaro, Doretta,Landi, Martina,D'Andrea, Felicia,Guazzelli, Lorenzo
, (2019)
Iminosugars are known glycosidase inhibitors which are the subject of drug development efforts against several diseases. The access to structurally-related families of iminosugars is of primary importance for running structure-activity relationship studie
Synthesis of, and lack of inhibition of a rhamnosidase by, both enantiomers of deoxyrhamnojirimycin and rhamnolactam: β-Mannosidase inhibition by δ-lactams
Fairbanks, Anthony J.,Carpenter, Neil C.,Fleet, George W. J.,Ramsden, Nigel G.,De Bello, I. Cenci,Winchester, Bryan G.,Al-Daher, Samer S.,Nagahashi, Gerry
, p. 3365 - 3376 (2007/10/02)
Synthesis of both enantiomers of deoxyrhamnojirimycin and rhamnonolactam from D- and L-gulonolactones are described. The effects as inhibitors of the enantiomeric deoxyrhamnojirimycins and rhamnonolactams on human liver glycosidases are compared with deoxymannojirimycin and mannonolactam. No significant inhibition of the activity of naringinase (an α-L-rhamnosidase) was caused by any of these compounds.
